<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04603469</url>
  </required_header>
  <id_info>
    <org_study_id>H-48044</org_study_id>
    <nct_id>NCT04603469</nct_id>
  </id_info>
  <brief_title>Hypotension in Children With Down Syndrome With Anesthesia Induction</brief_title>
  <official_title>Incidence of Hypotension in Children With Down Syndrome During Induction of Anesthesia With Sevoflurane</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Baylor College of Medicine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Baylor College of Medicine</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Children generally undergo induction of anesthesia by inhalation of sevoflurane. Children&#xD;
      with Down Syndrome experience bradycardia with induction of anesthesia using sevoflurane. It&#xD;
      is unknown if this bradycardia is isolate or results in hypotension, thus requiring&#xD;
      treatment. Isolate bradycardia without hypotension does not require treatment and should be&#xD;
      avoided as many of these patients have underlying cardiac anomalies.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Children generally undergo induction of anesthesia by inhalation of sevoflurane. This is&#xD;
      particularly relevant for children with developmental delays as to avoid placement of an IV&#xD;
      while awake. However, children with Down Syndrome experience bradycardia with induction of&#xD;
      anesthesia using sevoflurane. It is unknown if this bradycardia is isolate or results in&#xD;
      hypotension, thus requiring treatment. Isolate bradycardia without hypotension does not&#xD;
      require treatment and should be avoided as many of these patients have underlying cardiac&#xD;
      anomalies.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">October 21, 2020</start_date>
  <completion_date type="Anticipated">December 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Assessment of non-invasive blood pressure during induction</measure>
    <time_frame>5 minutes</time_frame>
    <description>non invasive blood pressure during induction (systolic, diastolic and Mean pressures)</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">45</enrollment>
  <condition>Hypotension on Induction</condition>
  <arm_group>
    <arm_group_label>Trisomy 21 patients</arm_group_label>
    <description>Children &lt;18 years old requiring general anesthesia with inhalation induction Down syndrome ASA physical classification 1-3</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Non invasive blood pressure</intervention_name>
    <description>measurement of blood pressure during induction of general anesthesia</description>
    <arm_group_label>Trisomy 21 patients</arm_group_label>
    <other_name>blood pressure</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is an observational study of children with down syndrome undergoing induction of&#xD;
        general anesthesia with sevoflurane. vital signs of blood pressure, heart rate and pulse&#xD;
        oximetry will be recorded on the anesthesia record as standard practice&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Children &lt;18 years old Requiring general anesthesia with inhalation induction Down syndrome&#xD;
        ASA physical classification 1-3&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients &gt;18 years of age Patients without down syndrome Cyanotic congenital heart disease&#xD;
        Use of antihypertensive medications Pulmonary hypertension patients undergoing intravenous&#xD;
        induction of anesthesia ASA physical classification other than 1-3 emergency procedure&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adam Adler, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Baylor College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Texas Childrens Hospital</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>October 21, 2020</study_first_submitted>
  <study_first_submitted_qc>October 21, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2020</study_first_posted>
  <last_update_submitted>September 29, 2021</last_update_submitted>
  <last_update_submitted_qc>September 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Baylor College of Medicine</investigator_affiliation>
    <investigator_full_name>Adam Adler MD, MS, FAAP</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Down Syndrome</mesh_term>
    <mesh_term>Hypotension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

